The neuron-specific deletion of IR or IGF-1R in the mouse model of AD provided a myriad of beneficial effects, manifested by decreased APP processing, fewer amyloid plaques, less amyloid-β, improved spatial memory, and protection from premature death (276–278). Here, APP is linked to Alzheimer disease.